Columbus Dispatch: Soaring Insulin Prices Show How the US is Losing the Battle Against High Drug Costs

According to a new bipartisan investigation, the cost of insulin has been kept artifically high.

The investigation found that drug manufacturers “aggressively” raised the list price of their leading insulin brands an average of 300% over the past decade.

Lifecare Alliance hands out supplies for diabetics but cannot provide insulin.